CN Patent

CN1427827A — 用于抗菌的2－羟基－姆替林氨基甲酸酯衍生物

Assigned to SmithKline Beecham Ltd · Expires 2003-07-02 · 23y expired

What this patent protects

式(I)的2－(S)－羟基姆替林(mutilin)氨基甲酸酯衍生物，其中R 1 是5－或6－元的可被取代或不被取代的杂芳基；以及R 2 是乙烯基或乙基，该化合物可用于治疗细菌性感染。

USPTO Abstract

式(I)的2－(S)－羟基姆替林(mutilin)氨基甲酸酯衍生物，其中R 1 是5－或6－元的可被取代或不被取代的杂芳基；以及R 2 是乙烯基或乙基，该化合物可用于治疗细菌性感染。

Drugs covered by this patent

lefamulin-acetate (LEFAMULIN ACETATE)

Patent Metadata

Patent number: CN1427827A
Jurisdiction: CN
Classification: —
Expires: 2003-07-02
Drug substance claim: No
Drug product claim: No
Assignee: SmithKline Beecham Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.